 |
Alefacept |
|---|---|
| Trade Name | Amevive |
| Orphan Indication | For use as prophylaxis of rejection in patients receiving allogenic solid organ transplants |
| USA Market Approval | USA |
| USA Designation Date | 2007-12-19 00:00:00 |
| Sponsor | Astellas Pharma Global Development, Inc.;Three Parkway North;Deerfield, Illinois, 60015 |
